Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02138097 · ClinicalTrials.gov registry record
Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 615,067
- Enrollment target
NCT02138097: Completed study, sponsored by Boehringer Ingelheim.
NCT02138097 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 615,067 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02138097 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 615,067 participants
- Enrollment target
Study Summary
This protocol is for a series of descriptive analyses conducted within a cohort of patients using linagliptin, other dipeptidyl peptidase-4 (DPP-4) inhibitors, and other oral and non-insulin injected hypoglycemic medications between May 2011 and July 2012. Understanding 1) the existing utilization patterns for linagliptin, sitagliptin, saxagliptin, and other oral and non-insulin injected hypoglycemic agents and (2) the differences in utilization patterns between these agents will help with the design, analysis and interpretation of comparative effectiveness and safety studies of linagliptin, other DPP-4 inhibitors, and other agents. The study will provide an overview of existing utilization patterns for linagliptin, other dipeptidyl peptidase-4 (DPP-4) inhibitors, other oral and non-insulin injected hypoglycemic agents, in order to detect potential selective prescribing patterns that might lead to channeling bias.
Primary Outcome
Number of patients initiating each individual agent divided by the number of patients initiating any oral or non-insulin injected hypoglycemic agent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 615,067 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-08 |
What the finished NCT02138097 record still lists
NCT02138097 is an observational study that tracks outcomes without assigning an intervention. Its 615,067 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02138097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02138097 about?
NCT02138097 is a clinical study titled "Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns". This protocol is for a series of descriptive analyses conducted within a cohort of patients using linagliptin, other dipeptidyl peptidase-4 (DPP-4) inhibitors, and other oral and non-insulin injected hypoglycemic medications between May 2011 and July 2012. Understanding 1) the existing utilization ...
What is the current status of trial NCT02138097?
This trial is currently completed. The enrollment target is 615,067 participants. The study started on 2014-05. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT02138097?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065060 · 500,000 participants
Parkinson Progression Marker Initiative Online (PPMI Online)
- NCT06017687 · 500,000 participants · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia